Published in Heart Fail Rev on November 22, 2007
Debate: Limitations on universality: the "right to health" and the necessity of legal nationality. BMC Int Health Hum Rights (2010) 1.12
ALDH2 in alcoholic heart diseases: molecular mechanism and clinical implications. Pharmacol Ther (2011) 1.09
NOX2 amplifies acetaldehyde-mediated cardiomyocyte mitochondrial dysfunction in alcoholic cardiomyopathy. Sci Rep (2016) 0.79
Alcohol's Burden on Immunity Following Burn, Hemorrhagic Shock, or Traumatic Brain Injury. Alcohol Res (2015) 0.77
Alcohol and immunology: Summary of the 2012 Alcohol and Immunology Research Interest Group (AIRIG) meeting. Alcohol (2013) 0.76
A case of heart failure due to alcoholic cardiomyopathy combined with acute pulmonary embolism. J Thorac Dis (2014) 0.75
Comparison of patients rehospitalized for heart failure with versus without a history of habitual alcohol consumption. Proc (Bayl Univ Med Cent) (2014) 0.75
Carnitine regulates myocardial metabolism by Peroxisome Proliferator-Activated Receptor-alpha (PPARalpha) in alcoholic cardiomyopathy. Med Sci Monit (2011) 0.75
A 56-year-old man with co-prevalence of Leriche syndrome and dilated cardiomyopathy: case report and review. Wien Klin Wochenschr (2013) 0.75
Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction (1993) 41.55
Comparison of questionnaire and laboratory tests in the detection of excessive drinking and alcoholism. Lancet (1982) 3.11
Alcohol intake assessment: the sober facts. Am J Epidemiol (1999) 2.69
Hardcore drug users claim to be occasional users: drug use frequency underreporting. Drug Alcohol Depend (2000) 1.32
Alcohol and the cardiovascular system. JAMA (1990) 1.10
Validity of self-report in alcoholism research: results of a Veterans Administration Cooperative Study. Alcohol Clin Exp Res (1988) 0.96
Effects of alcohol on the heart. Curr Opin Crit Care (2001) 0.93
Fatty acid ethyl esters: potentially toxic products of myocardial ethanol metabolism. J Mol Cell Cardiol (1998) 0.91
Alcoholic cardiomyopathy. Cardiovasc Drugs Ther (1994) 0.82
The effects of alcohol on the heart: detrimental or beneficial? Postgrad Med (1997) 0.80
Normalization of variables of left ventricular function in patients with alcoholic cardiomyopathy after cessation of excessive alcohol intake: an echocardiographic study. Eur Heart J (1987) 0.80
Alcohol and congestive heart failure. Alcohol Clin Exp Res (1998) 0.75
No more surprises: screening patients for alcohol abuse. Am J Nurs (2000) 0.75
Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study. J Am Coll Cardiol (2008) 2.89
Sleep disordered breathing, daytime symptoms, and functional performance in stable heart failure. Sleep (2010) 1.00
Suppression of ventricular tachycardia with dronedarone: a case report. J Cardiovasc Electrophysiol (2011) 0.93
Nocturia, sleep and daytime function in stable heart failure. J Card Fail (2012) 0.88
Psychological and social factors that correlate with dyspnea in heart failure. Psychosomatics (2006) 0.84
Atrial fibrillation in patients with heart failure: Role of catheter ablation therapies. Exp Clin Cardiol (2012) 0.76
A call to disarm: is malignancy higher in post-transplant patients? J Heart Lung Transplant (2006) 0.75
Influence of age, gender, and race on depression in heart failure patients. J Am Coll Cardiol (2004) 0.75
Atrial fibrillation following cardiac surgery: established and emerging strategies of prevention. Recent Pat Cardiovasc Drug Discov (2011) 0.75
Venous thromboembolism in patients with heart failure: in-hospital and chronic use of anti-coagulants for prevention. Recent Pat Cardiovasc Drug Discov (2012) 0.75
On-X Valve: The Next Generation Aortic Valve. Cardiol Rev (2017) 0.75
Reply: Do We Need Individualized Therapeutic Strategies in High-Risk Patients Treated With Hypothermia? JACC Cardiovasc Interv (2017) 0.75
Cardiotoxicity of Anticancer Therapies. Rev Cardiovasc Med (2015) 0.75
Ranolazine--treatment of ventricular tachycardia and symptomatic ventricular premature beats in ischemic cardiomyopathy. Pacing Clin Electrophysiol (2010) 0.75